Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
Go back to Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022| Quest Diagnostics (NYSE: DGX) | Delayed: 235.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $235.50 | 52 Week High | $86.85 | |||
| Open | $235.50 | 52 Week Low | $59.66 | |||
| Day High | $235.50 | P/E | 44.35 | |||
| Day Low | $235.50 | EPS | $5.31 | |||
| Volume | 910 | |||||

